Data / Form D filings / Salarius Pharmaceuticals, LLC
Salarius Pharmaceuticals, LLC: Form D filings
Salarius Pharmaceuticals, LLC, a pharmaceuticals company in Holladay, UT, filed 3 Form D notices with the SEC in 2016. The latest, on November 21, 2016, reports $131,500 sold of a $131,500 offering to 7 investors.
Find out what Salarius Pharmaceuticals, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5361 South 2110 East, Holladay, UT, 84117
- Phone
- (203) 546-0376
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1661178
The full lists. Form D filings in Utah: 660 rows, $33, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 21, 2016 | New notice | $131,500 | $131,500 | $0 | 7 | Mar 22, 2014 | sec.gov |
| Nov 21, 2016 | New notice | $108,335 | $108,335 | $0 | 8 | Mar 21, 2013 | sec.gov |
| Apr 4, 2016 | New notice | $2,745,000 | $775,000 | $1,970,000 | 3 | Apr 30, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sunil J. Sharma | Executive Officer, Director, Promoter | |
| Jonathan J. Northrup | Executive Officer, Director, Promoter | |
| David J. Bearss | Executive Officer, Director, Promoter | |
| David J. Arthur | Executive Officer |
Every Form D from the week of Nov 21, 2016 · All recent filings in Utah · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Salarius Pharmaceuticals, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.